Corpus Intelligence IC Memo — BUCYRUS COMMUNITY HOSPITAL 2026-04-26 21:28 UTC
IC Memo — BUCYRUS COMMUNITY HOSPITAL
Investment Committee Memorandum | OH | 25 beds | Grade C | EBITDA uplift $5.4M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

BUCYRUS COMMUNITY HOSPITAL

CCN 361316 | CRAWFORD, OH | 25 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

BUCYRUS COMMUNITY HOSPITAL is a 25-bed suburban community hospital in CRAWFORD, OH with $73.0M in net patient revenue and a 28.9% operating margin. The hospital serves a payer mix of 36.7% Medicare, 0.9% Medicaid, and 62.4% commercial.

Thesis: Turnaround. Our ML models identify $5.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 28.9% to 36.3% (+736bps).

Net Revenue HCRIS$73.0M
Current EBITDA COMPUTED$21.1M
Operating Margin COMPUTED28.9%
Occupancy HCRIS49.1%
Revenue / Bed COMPUTED$2.9M
Net-to-Gross HCRIS38.6%
Distress Probability ML46.1%

2. Market Context & Competitive Position

235
OH Hospitals
-0.3%
State Median Margin
82
Comparable Hospitals

OH has 235 Medicare-certified hospitals with a median operating margin of -0.3%. The target's margin of 28.9% places it above the state median. Among 82 size-comparable peers (12-50 beds), the median margin is -2.5%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (12-50), prioritizing same-state peers. 82 hospitals in the comp set.

HospitalStateBedsRevenueMargin
BUCYRUS COMMUNITY HOSPITAL (Target)OH25$73.0M28.9%
THE SURGICAL HOSPITAL AT SOUTHOH24$166.6M-3.1%
GALION COMMUNITY HOSPITALOH25$128.2M16.6%
MARY RUTAN HOSPITALOH39$113.0M-12.5%
AVITA ONTARIO HOSPITALOH49$109.2M16.0%
MERCY HEALTH-TIFFIN HOSPITAL OH35$103.0M18.1%
ALLIANCE COMMUNITY HOSPITALOH50$100.2M-3.5%
JOINT TOWNSHIP DISTRICT MEMORIOH33$95.6M9.3%
FULTON COUNTY HEALTH CENTEROH25$95.2M-7.4%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $5.4M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.5M+210bp18mo
Cost to Collect4.5%2.5%$1.5M+200bp12mo
Denial Rate Reduction12.0%6.5%$1.4M+198bp12mo
A/R Days Reduction5200.0%3800.0%$889K+122bp9mo
Clean Claim Rate88.0%96.0%$47K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.5M
Cost to Collect
$1.5M
Denial Rate Reduction
$1.4M
A/R Days Reduction
$889K
Clean Claim Rate
$47K
Total EBITDA Uplift$5.4M
Current EBITDA$21.1M
+ RCM Uplift+$5.4M
Pro Forma EBITDA$26.5M
Current Margin28.9%
Pro Forma Margin36.3%
WC Released (1x)$2.8M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$32.5M$192.9M5.94x42.8%
Base (11x exit)10.0x11.0x$32.5M$222.7M6.86x47.0%
Bull Case9.0x11.0x$29.2M$251.0M8.59x53.8%
Bull (12x exit)9.0x12.0x$29.2M$282.4M9.67x57.4%
Bear Case11.0x10.0x$35.7M$155.5M4.36x34.2%
Bear (11x exit)11.0x11.0x$35.7M$182.6M5.12x38.6%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumStandard execution riskRCM improvement requires management buy-in and 12-18 month implementation timeline

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 82 hospitals with 12-50 beds
  • Same-state prioritization (n=83)
  • Comp margins: P25=-11.5% / P50=-2.5% / P75=11.0%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.